Table 1.
The characteristics of patients
| Gender | Age | PRISM III | Lowest P/F ratio | Maximum DIC score | Pathogen in TLF/NPA/blood on PICU admission | Complicatios and past history | PICU admission day from the onset | LOS in PICU | LOS in Hospital | Outcome | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Case 1 | F | 2 M | 10 | 36 | 7 | RSV, CMVa | None | 6 | 10 | 21 | Alive |
| Case 2 | F | 2Y5M | 3 | 35 | 6 | TB, CMVa | None | 20 | 32 | 33 | Alive |
| Case 3 | M | 1Y5M | 5 | 77 | 7 | A/H1N1pdm, CMV* | Recurrent pneumonia | 8 | 13 | 27 | Alive |
| Case 4 | M | 3 M | 10 | 69 | 6 | PCP/CMV, HIV | Recurrent pneumonia, HIV positive | 9 | 8 | 34 | Alive |
| Case 5 | F | 3 M | 10 | 68 | 5 | CMV | None | 8 | 17 | 17 | Dead |
| Case 6 | F | 9Y5M | 12 | 46 | 6 | VZV, RV | None | 12 | 14 | 14 | Dead |
PRISM Pediatric risk score for mortality, P/F ratio PaO2/FiO2 ratio, DIC disseminated intravascular coagulopathy, TLF tracheal lavage fluid, NPA; nasopharyngeal aspiration, RSV Respiratory syncytial virus, CMV cytomegalovirus, TB tuberculous, A/H1N1pdm Influenza A, subtype H1N1pdm, PCP pneumocystis jiroveci, HIV human immunodeficiency virus, VZV varicella zoster virus, RV Rhino virus, LOS Length of stay
aCMV CMV latent infection